Clinical Trial Update: A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for I-131 Omburtamab in Desmoplastic Small Round Cell Tumor and other peritoneal cancers; the study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor
• Peritoneal Cancer
• Peritoneal Carcinoma

Drugs mentioned

• I-131 Omburtamab (omburtamab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Desmoplastic Small Round Cell Tumor, Peritoneal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING